Liom develops the ultimate wearable to monitor needle-free biomarkers, beginning with glucose.
Liom has raised $25.0M in total funding. The most recent round was Series A. The last funding was announced in December 2024.
Liom's investors include b2venture, Ornament Health, Daniel Gutenberg, Kirill Eves, Konstantin Othmer.
Liom is headquartered in Pfäffikon, Switzerland.
Liom develops the ultimate wearable to monitor needle-free biomarkers, beginning with glucose.
Liom is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Liom — Funding & Investors." VCBacked, December 3, 2024, https://www.vcbacked.co/company/liom. Accessed July 31, 2026.
VCBacked. (2024). Liom — Funding & Investors. Retrieved July 31, 2026, from https://www.vcbacked.co/company/liom
{{cite web |title=Liom — Funding & Investors |url=https://www.vcbacked.co/company/liom |website=VCBacked |access-date=July 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated